ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Bioinformatics"

  • Abstract Number: 1964 • 2018 ACR/ARHP Annual Meeting

    Epigenetic Changes of Energy Metabolism-Related Genes in Rheumatoid Arthritis Fibroblast-like Synoviocytes

    Brian Pedersen1, Roxana Coras1,2, Wei Wang3, Gary S. Firestein1 and Monica Guma1,2, 1Medicine, University of California San Diego, La Jolla, CA, 2Medicine, Autonomous University of Barcelona, Bellatera, Spain, 3Chemistry and Biochemistry, University of California San Diego, La Jolla, CA

    Background/Purpose: Epigenetic changes contribute to the pathogenesis of rheumatoid arthritis (RA) and a comprehensive epigenomic characterization of RA fibroblast-like synoviocytes (FLS) has recently been described.…
  • Abstract Number: 1974 • 2018 ACR/ARHP Annual Meeting

    Dynamics of Transcriptional Signatures from Synovial Macrophage Subsets during Acute and Chronic Murine Models of Inflammatory Arthritis

    Philip J. Homan1, Anna B Montgomery2, Salina Dominguez3, Carla M. Cuda3, Harris Perlman3 and Deborah R. Winter3, 1Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Department of Medicine Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Macrophages play an integral role in the progression and persistence of rheumatoid arthritis (RA) through production of degradative enzymes, cytokines, and chemokines and recruitment…
  • Abstract Number: 2115 • 2018 ACR/ARHP Annual Meeting

    Identification of Systemic Lupus Erythematosus Subgroups Using Electronic Health Record and Genetic Databases

    Milena Gianfrancesco1, Ishan Paranjpe2, Julia Kay3, Joanne Nitiham4, Kimberly Taylor5, Cristina Lanata1, Marina Sirota6, Lindsey A. Criswell7, Gabriela Schmajuk8 and Jinoos Yazdany2, 1Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA, 3Medicine/Rheumatology, University of California - San Francisco, San Francisco, CA, 4Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, University of California, San Francisco, San Francisco, CA, 5University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA, 6Pediatrics, Institute for Computational Health Sciences, University of California, San Francisco, San Francisco, CA, 7University of California San Francisco, San Francisco, CA, 8San Francisco VA Medical Center, San Francisco, CA

    Background/Purpose: Systemic lupus erythematosus (SLE) is a multifactorial disease with genetic and environmental risk factors, and heterogeneous manifestations that encompass a wide range of disease…
  • Abstract Number: 2123 • 2018 ACR/ARHP Annual Meeting

    Analysis of Lupus Synovitis Gene Expression Reveals Dysregulation of Pathogenic Pathways Activated within Infiltrating Immune Cells

    Erika Hubbard, Michelle Catalina, Sarah Heuer, Prathyusha Bachali, Nick Geraci, Isabella Blanco, Robert Robl, Peter Lipsky and Amrie Grammer, AMPEL BioSolutions and RILITE Research Institute, Charlottesville, VA

    Background/Purpose: Arthritis is a common manifestation of SLE but the inflammatory and immune cells that infiltrate synovium and the signaling pathways activated are not well…
  • Abstract Number: 177 • 2017 ACR/ARHP Annual Meeting

    Intronic Variants of the B-Cell Proliferator RASGRP3 Affect Its Expression, and Might Contribute to Lupus Risk

    Bhupinder Singh1, Philip Borden2, Julio Molineros3, Celi Sun3, Loren Looger2 and Swapan Nath1, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, OKlahoma City, OK, 2Howard Hughes Medical Institute, Ashburn, VA, 3Oklahoma Medical Research Foundation, OKlahoma City, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) is an inflammatory autoimmune disease with complex genetic underpinnings. Variants from RASGRP3 (RAS Guanyl Releasing Protein 3) is one of…
  • Abstract Number: 183 • 2017 ACR/ARHP Annual Meeting

    Allele-Dependent Binding of a Viral Protein to Autoimmune Disease-Associated Genetic Variants

    Matthew Weirauch1, Daniel Miller2, Leah C. Kottyan3, Ignacio Ibarra4, Arthur Lynch2, Sayeed Syed5, Xiaoting Chen2, Erin Zoller2, Connor Schroeder2, Josh Lee2, Albert Magnusen6, Ally Yang7, Timothy R. Hughes7, Joo-Seop Park8, Charles Vinson5 and John B. Harley2,9, 1Center for Autoimmune Genomics and Etiology (CAGE) and Divisions of Biomedical Informatics and Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Center for Autoimmune Genomics and Etiology (CAGE), Division of Allergy and Immunology, Cincinnati Children's Hospital, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany, 5NCI, Bethesda, MD, 6Center of Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 7University of Toronto, Toronto, ON, Canada, 8Divisions of Urology and Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 9US Department of Veterans Affairs Medical Center, Cincinnati, OH

    Background/Purpose: Risk factors are known for many diseases, but the etiologies of most autoimmune diseases remain unknown and are idiopathic. Pathogenesis of disease likely involves…
  • Abstract Number: 184 • 2017 ACR/ARHP Annual Meeting

    An Epigenome-Guided Approach to Causal Variant Discovery in Autoimmune Disease

    Richard C. Pelikan1, Jennifer A. Kelly2, Yao Fu2, Caleb Lareau3, Graham B. Wiley1, Stuart Glenn1, Martin Aryee3,4, Courtney Montgomery5 and Patrick Gaffney2, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Department of Biostatistics, Harvard T.H. Chan School of Public Health, Charlestown, MA, 4Department of Pathology, Harvard Medical School, Boston, MA, 5Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Genome-wide association studies have identified thousands of genetic associations with complex human diseases and traits. However, establishing the truly causal regions of risk haplotypes…
  • Abstract Number: 1334 • 2017 ACR/ARHP Annual Meeting

    Identification of Key Regulators for Resolution of Chronic Inflammatory Arthritis through a Systems Approach

    Jin-Sun Kong Sr.1, Ji-Hwan park2, Seung-Ah Yoo Sr.1, Jung Hee Koh3, Daehee Hwang4 and Wan-Uk Kim Sr.5, 1The Catholic University of Korea, Center for Integrative Rheumatoid Transcriptomics and Dynamics, seoul, Korea, Republic of (South), 2Center for Plant Aging Research, DGIST, Daegu 42988, South Korea, Daegu, Korea, Republic of (South), 3Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), 4Center for Plant Aging Research, DGIST, Daegu 42988, South Korea, Department of New Biology, DGIST, Daegu 42988, South Korea, Daegu, Korea, Republic of (South), 5The Catholic University of Korea, Department of Internal Medicine, seoul, Korea, Republic of (South)

    Background/Purpose: Collagen-induced arthritis(CIA), a representative animal model of chronic inflammatory arthritis, follows phases of induction, peak of inflammation and resolution. This study aims to identify…
  • Abstract Number: 2405 • 2017 ACR/ARHP Annual Meeting

    Biological Function Integrated Prediction of Severe Radiographic Progression in Rheumatoid Arthritis: A Nested Case Control Study

    Young Bin Joo1, Yul Kim2, Youngho Park3, Kwangwoo Kim4, Jeong Ah Ryu5, Seunghun Lee6, So-Young Bang7, Hye-Soon Lee8, Gwan-Su Yi9 and Sang-Cheol Bae7, 1Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea, Republic of (South), 2Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea, Republic of (South), 3Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South), 44Department of Biology, Kyung Hee University, Seoul, Korea, Republic of (South), 5Department of Radiology, Hanyang University Hospital, Seoul, Korea, Republic of (South), 617 Haengdang-Dong, Seongdong-G, Hanyang University Hospital, Seoul, Korea, Republic of (South), 7Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South), 8Hanyang University Guri Hospital, Gyeonggi-do, Korea, Republic of (South), 9Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea, Republic of (South)

    Background/Purpose: Radiographic progression is reported to be highly heritable in rheumatoid arthritis (RA). However, previous study using genetic loci showed an insufficient accuracy of prediction…
  • Abstract Number: 2931 • 2017 ACR/ARHP Annual Meeting

    Multi-Organ RNA-Sequencing of Patients with Systemic Sclerosis (SSc) Finds That Intrinsic Subsets Are Conserved across Organ Systems

    Bhaven K. Mehta1, Jennifer Franks2, Guoshuai Cai2, Diana Toledo3, Tammara A. Wood2, Kimberly A. Archambault1, Noelle Kosarek1, Kathleen Kolstad4, Marianna Stark5, Antonia Valenzuela6, David Fiorentino7, Nielsen Fernandez-Becker8, Laren Becker8, Linda Nguyen8, John Clarke9, Francesco Boin10, Paul Wolters11, Lorinda Chung12 and Michael L. Whitfield1, 1Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 2Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 3Department of Molecular & Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 4Rheumatology, Stanford University Medical Center, Stanford, CA, 5Stanford University, Stanford, CA, 6Stanford University School of Medicine, Stanford, CA, 7Department of Dermatology, Stanford University School of Medicine, Palo Alto, CA, 8Gastroenterology & Hepatology, Stanford University School of Medicine, Palo Alto, CA, 9Medicine/Gastroenterology, Stanford University, Stanford, CA, 10Rheumatology, University California, San Francisco, San Francisco, CA, 11Pulmonary Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, 12Rheumatology, Stanford University Medical Center, Palo Alto, CA

    Background/Purpose: While skin fibrosis is a hallmark of systemic sclerosis (SSc), internal organ involvement is the primary cause of morbidity and mortality, often related to…
  • Abstract Number: 41 • 2017 ACR/ARHP Annual Meeting

    A Fine Bioinformatical Analysis of Lymphocyte Distribution Predicts the Diagnosis of Systemic Autoimmune Diseases

    Quentin Simon1, Bénédicte Rouvière1, Tifenn Martin1, Lucas Le Lann1, Alain Saraux1, Valérie Devauchelle-Pensec1, Concepcion Marañón2, Nieves Varela Hernández2, Aleksandra Dufour3, Carlo Chizzolini4, Ellen de Langhe5, Nuria Barbarroja6, Chary Lopez-Pedrera7, Velia Gerl8, Aurelie Degroof9, Julie Ducreux10, Elena Trombetta11, Tianlu Li12, Marta Alarcón-Riquelme13, Christophe Jamin1 and Jacques-Olivier Pers1, 1U1227, Université de Brest, Inserm, Labex IGO, CHU de Brest, Brest, France, 2GENYO, Centre for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, Granada, Spain, 3Immunology & Allergy, University Hospital and School of Medicine, Geneva, Switzerland, 4University hospital of Geneva, Geneva, Switzerland, 5Rheumatology, University Hospital KU Leuven, Leuven, Belgium, 6Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 7IMIBIC/Reina Sofia Hospital/ University of Cordoba, Cordoba, Spain, 8Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, 9Pôle de Maladies Rhumatismales, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium, 10Pôle de pathologies rhumatismales inflammatoires et systémiques, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium, 11Laboratorio di Analisi Chimico Cliniche e Microbiologia - Servizio di Citofluorimetria, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy, 12Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain, 13GENYO. Center for Genomics and Oncological Research, Granada, Spain

    Background/Purpose : We investigated 194 individuals with SADs (38 primary Sjögren’s syndrome (pSS), 47 rheumatoid arthritis (RA), 46 systemic lupus erythematosus (SLE), 42 systemic sclerosis…
  • Abstract Number: 799 • 2016 ACR/ARHP Annual Meeting

    Biomarker Identification & Molecular Sub-Classification in Systemic Sclerosis for Precision Medicine Using RNA-Seq

    Elisha D.O. Roberson1,2, Li Cao1, David J. Morales-Heil1, Benjamin Korman3 and John Varga4, 1Department of Medicine, Washington University, St. Louis, MO, 2Department of Genetics, Washington University, St. Louis, MO, 3Department of Rheumatology, Northwestern University, Feinberg School of Medicine Scleroderma Program, Chicago, IL, 4Rheumatology and Dermatology, Northwestern University, Feinberg School of Medicine Scleroderma Program, Chicago, IL

    Background/Purpose: Systemic sclerosis (SSc) is a complex and highly heterogeneous disease with multi-organ involvement. Accurate tools for disease sub-classification are lacking. In most patients, skin…
  • Abstract Number: 807 • 2016 ACR/ARHP Annual Meeting

    A Novel Multi-Network Approach Reveals Tissue-Specific Cellular Modulators of Fibrosis in Systemic Sclerosis, Pulmonary Fibrosis and Pulmonary Arterial Hypertension

    Jaclyn N. Taroni1, Casey S. Greene2, Tammara A. Wood3, Romy B. Christmann4, Harrison W. Farber5, Robert A. Lafyatis6, Christopher Denton7, Monique Hinchcliff8, Patricia A. Pioli9, Michael L. Whitfield10 and J. Matthew Mahoney11, 1Department of Molecular & Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 2Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, 3Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 4Division of Rheumatology, Boston University Medical School, Boston, MA, 5Pulmonary Center, Boston University Medical Center, Boston, MA, 6Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 7Division of Medicine, Centre for Rheumatology and Connective Tissue Disease, University College London, London, United Kingdom, 8Northwestern University, Feinberg School of Medicine Scleroderma Program, Chicago, IL, 9Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, 10Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 11Department of Neurological Sciences, College of Medicine, University of Vermont, Burlington, VT

    Background/Purpose: Systemic sclerosis (SSc) is characterized by multi-organ involvement and clinical heterogeneity. “Big data” approaches have yielded powerful tools to infer tissue-specific pathobiology. Large amounts of…
  • Abstract Number: 1201 • 2016 ACR/ARHP Annual Meeting

    Deconvolution of Immune Cell Proportions from Whole Blood RNA Using Next-Generation Sequencing

    Omar Jabado1, Sarah Hu2, Julie Carman3, Suzanne Suchard3, Deborah Lee4, Zhenhao Qi5, Stefan Kirov6, Ryan Golhar7, Aiqing He7, Cate Speake8, Peter S. Linsley8, Steven G. Nadler9 and Somnath Bandyopadhyay2, 13551 Lawrenceville Princeton, Bristol-Myers Squibb, Princeton, NJ, 2Bristol-Myers Squibb, Princeton, NJ, 3Discovery Translational Sciences Group, Bristol-Myers Squibb, Princeton, NJ, 4Discovery Immunoscience, Bristol-Myers Squibb, Princeton, NJ, 5Exploratory Clinical and Translational Research, Bristol-Myers Squibb, Princeton, NJ, 6Genetically Defined Diseased & Genomics, Bristol-Myers Squibb, Princeton, NJ, 7Genetically Defined Diseases & Genomics, Bristol-Myers Squibb, Princeton, NJ, 8Systems Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, 9Immunosciences Translational Research, Bristol-Myers Squibb, Princeton, NJ

    Background/Purpose: Measurements of immune cell proportions from whole blood can be used to detect pharmacodynamic effects, as a marker for prognosis and to aid in…
  • Abstract Number: 1207 • 2016 ACR/ARHP Annual Meeting

    Design of a Multiplex Serum Proteome Assay to Monitor Biologic Drug Response in Rheumatoid Arthritis Patients

    Niamh Callan1, Aisha Butt1, Stephen R. Pennington2, Cathy McGeough3, Philip Gardiner4, Gary Wright5, Tony Bjourson3 and David S. Gibson6, 1Proteome Research Centre, Conway Institute, University College Dublin, Dublin, Ireland, 2Proteome Research Centre, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland, 3Northern Ireland Centre for Stratified Medicine, Ulster University, Londonderry, United Kingdom, 4Rheumatology, Altnagelvin Hospital, Londonderry, United Kingdom, 5Rheumatology, Musgrave Park Hospital, BELFAST, United Kingdom, 6Inflammatory Disease Research Group, Northern ireland Centre for Stratified Medicine, Ulster University, Londonderry, United Kingdom

    Background/Purpose: Biologic drugs have revolutionised the treatment of Rheumatoid Arthritis (RA), however these therapies are expensive and exhibit a high non–response rate (30%). Currently there…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology